Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?

NCT ID NCT06316739

Prevention Sponsor: North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This pilot trial tests whether training Gancheros—people who provide injection services in exchange for money or drugs—can lower HIV, hepatitis C, and overdose risks among migrant Puerto Rican people who inject drugs in New York City. Gancheros will attend six sessions on prevention and then share supplies like sterile syringes and naloxone with their clients over four months. The study will assess whether clients use sterile syringes and carry naloxone more often.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a behavioral intervention training Gancheros in HIV, HCV, and overdose prevention outreach
What this could lead to
If successful, this approach could offer a community-driven way to reduce HIV, hepatitis C, and overdose risks among a hard-to-reach population.
What could go wrong
This is a small pilot study with only 10 Gancheros and 60 clients, so results may not apply broadly. The intervention depends on Gancheros' willingness and ability to share prevention messages and supplies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

69 people

The number who actually took part.

Started

May 2024

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Two distinct groups of participants with different eligibility criteria will be enrolled: (1) Gancheros (n=10, 5/neighborhood); and (2) Gancheros' clients (n=60, 30/neighborhood). 1. Ganchero participants: * Inclusion Criteria: * A migrant person who injects drugs (PWID) from Puerto Rico living in one of 2 pre-selected neighborhoods in the Bronx, New York City (NYC) * Past experience providing Ganchero services in Puerto Rico * Currently provides Ganchero services to ≥10 clients/day * Speaks Spanish or English * Exclusion Criteria: * Planned travel away from NYC for 2 weeks or longer over the next 24 months * Inability to comprehend trial information or provide informed consent (e.g., due to intoxication) 2. Client participants: * Inclusion Criteria: * A migrant PWID from Puerto Rico living in one of 2 pre-selected neighborhoods in the Bronx, NYC * Referred to the study by a participating Ganchero * Used the services of their nominating Ganchero at least once/week for the past 90 days * Speaks Spanish or English * Exclusion Criteria: * Inability to comprehend trial information or provide informed consent (e.g., due to intoxication)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute opioid poisoning Drug Overdose hepatitis C virus infection HIV infectious disease poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HCV HIV infections Overdose

Contacts and locations

Locations

  • CUNY Graduate School of Public Health & Health Policy

    New York, New York, 10027, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.